Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

25-hydroxyvitamin D is a predictor of COVID-19 severity of hospitalized patients

Nguyen et al., PLOS ONE, doi:10.1371/journal.pone.0268038
May 2022  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality 81% Improvement Relative Risk Ventilation 53% Discharge 74% Vitamin D for COVID-19  Nguyen et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective study in the USA (July - October 2020) Lower mortality (p=0.0084) and higher discharge (p<0.0001) c19early.org Nguyen et al., PLOS ONE, May 2022 Favorsvitamin D Favorscontrol 0 0.5 1 1.5 2+
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020, now with p < 0.00000000001 from 122 studies, recognized in 9 countries.
No treatment is 100% effective. Protocols combine treatments.
5,100+ studies for 112 treatments. c19early.org
Retrospective 88 COVID-19 hospitalized patients and 122 controls, showing higher mortality, ventilation, and length of stay with vitamin D deficiency.
This is the 133rd of 210 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 144,755,650 vigintillion).
risk of death, 81.1% lower, OR 0.19, p = 0.008, cutoff 20ng/mL, adjusted per study, inverted to make OR<1 favor high D levels (≥20ng/mL), 25-OH-D3, multivariable, RR approximated with OR.
risk of mechanical ventilation, 52.8% lower, OR 0.47, p = 0.13, cutoff 20ng/mL, adjusted per study, inverted to make OR<1 favor high D levels (≥20ng/mL), 25-OH-D3, multivariable, RR approximated with OR.
risk of no hospital discharge, 74.0% lower, HR 0.26, p < 0.001, cutoff 20ng/mL, 25-OH-D3, Cox proportional hazards.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Nguyen et al., 3 May 2022, retrospective, USA, peer-reviewed, 11 authors, study period 15 July, 2020 - 15 October, 2020. Contact: nguyen.nguyen2@bswhealth.org.
This PaperVitamin DAll
25-hydroxyvitamin D is a predictor of COVID-19 severity of hospitalized patients
Nguyen N Nguyen, Muppala N P Raju, Briget Da Graca, Dapeng Wang, Nada A Mohamed, Manohar B Mutnal, Arundhati Rao, Monica Bennett, Matthew Gokingco, Huy Pham, Amin A Mohammad
PLOS ONE, doi:10.1371/journal.pone.0268038
Objectives Studies investigating the association between vitamin D and severity of COVID-19 have mixed results perhaps due to immunoassay assessment of total 25-hydroxyvitamin D (tD) (the sum of 25-hydroxyvitamin-D2 [25-OH-D2] and 25-hydroxyvitamin-D3 [25-OH-D3]). Liquid chromatography tandem mass spectrometry (LC-MS/MS) has high analytical specificity and sensitivity for 25-OH-D2 and 25-OH-D3, and thus enables a more accurate assessment of impact on COVID-19 outcomes. Methods We established reference intervals for 25-OH-D3 and tD using LC-MS/MS. 25-OH-D2, 25-OH-D3 and tD were quantitated for 88 COVID-19 positive and 122 COVID-19 negative specimens. Chi-square or Fisher's exact tests were used to test associations in binary variables. T-Tests or Wilcoxon rank sum tests were used for continuous variables. Cox proportional hazards were used to test associations between 25-OH-D3 or tD levels and length of stay (LOS). For mortality and ventilation, logistic regression models were used. Results COVID-19 patients with deficient (<20 ng/mL) levels of 25-OH-D3 had significantly longer LOS by 15.3 days. COVID-19 P patients with deficient (<20 ng/mL) and insufficient (<30 ng/ mL) of tD had significantly longer LOS by 12.1 and 8.2 days, respectively. Patients with insufficient levels of tD had significantly longer LOS by 13.7 days. COVID-19 patients with deficient serum 25-OH-D3 levels had significantly increased risk-adjusted odds of in-hospital mortality (OR [95% CI]: 5.29 [1.53-18.24]); those with insufficient 25-OH-D3 had significantly increased risk for requiring ventilation during hospitalization was found at LCMS insufficient cutoff (OR [95%
Supporting information S1 Table. Full models for adjusted evaluation of mortality, need for ventilation, and LOS. Full models for adjusted evaluation of mortality, need for ventilation, and LOS for COVID-19 positive patients at deficiency and insufficiency cutoffs for 25-OH-D3 and tD. Logistic regression was used for mortality and ventilation, and Cox proportional hazards was used for LOS.
References
Annweiler, Corvaisier, Gautier, Dube ´e, Legrand et al., Vitamin D supplementation associated to better survival in hospitalized frail elderly COVID-19 patients: the GERIA-COVID quasi-experimental study, Nutrients, doi:10.3390/nu12113377
Benton, Tetteh, Needham, Mu ¨cke, Sheppard et al., Evaluation of the 25-hydroxy vitamin D assay on a fully automated liquid chromatography mass spectrometry system, the Thermo Scientific Cascadion SM Clinical Analyzer with the Cascadion 25-hydroxy vitamin D assay in a routine clinical laboratory, Clin Chem Lab Med, doi:10.1515/cclm-2019-0834
Cascadiontm, 25-Hydroxy Vitamin D Assay
Castillo, Costa, Barrios, Alcala ´dı ´az, Lo ´pez Miranda et al., Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study, J Steroid Biochem Mol Biol, doi:10.1016/j.jsbmb.2020.105751
Daneshkhah, Agrawal, Eshein, Subramanian, Roy et al., Evidence for possible association of vitamin D status with cytokine storm and unregulated inflammation in COVID-19 patients, Aging Clin Exp Res, doi:10.1007/s40520-020-01677-y
Gauzzi, Purificato, Donato, Suppressive effect of 1alpha,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis, J Immunol, doi:10.4049/jimmunol.174.1.270
Giustina, Adler, Binkley, Consensus statement from 2 nd International Conference on Controversies in Vitamin D, Rev Endocr Metab Disord, doi:10.1007/s11154-019-09532-w
Gombart, Pierre, Maggini, A Review of Micronutrients and the Immune System-Working in Harmony to Reduce the Risk of Infection, Nutrients
Grant, Lahore, Mcdonnell, Baggerly, French et al., Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths, Nutrients
Heaney, Dowell, Hale, Bendich, Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D, J Am Coll Nutr, doi:10.1080/07315724.2003.10719287
Herna, Nan, Fernandez-Ayala, Garcı ´a-Unzueta, Herna ´ndez-Herna ´ndez et al., Vitamin D status in hospitalized patients with SARS-CoV-2 infection, The Journal of clinical endocrinology and metabolism
Hossein-Nezhad, Holick, Vitamin D for health: a global perspective, Mayo Clin Proc, doi:10.1016/j.mayocp.2013.05.011
Hossein-Nezhad, Spira, Holick, Influence of vitamin D status and vitamin D 3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial, PLoS One, doi:10.1371/journal.pone.0058725
Kaufman, Niles, Kroll, Bi, Holick, SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels, PLoS One, doi:10.1371/journal.pone.0239252
Lemire, Archer, Beck, Spiegelberg, Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions, J Nutr, doi:10.1093/jn/125.suppl%5F6.1704S
Meltzer, Best, Zhang, Vokes, Arora et al., Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results, JAMA Netw Open, doi:10.1001/jamanetworkopen.2020.19722
Mohan, Cherian, Sharma, Exploring links between vitamin D deficiency and COVID-19, PLoS Pathog, doi:10.1371/journal.ppat.1008874
Murai, Fernandes, Sales, Pinto, Goessler et al., Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: a randomized clinical trial, Jama, doi:10.1001/jama.2020.26848
Nowson, Mcgrath, Ebeling, Vitamin D and health in adults in Australia and New Zealand: a position statement, Med J Australia, doi:10.5694/mja11.10301
Nurminen, Seuter, Carlberg, Primary Vitamin D Target Genes of Human Monocytes, Front Physiol, doi:10.3389/fphys.2019.00194
Radujkovic, Hippchen, Tiwari-Heckler, Dreher, Boxberger, Vitamin D deficiency and outcome of COVID-19 patients, Nutrients
Thacher, Clarke, Vitamin D Insufficiency, Mayo Clin Proc, doi:10.4065/mcp.2010.0567
{ 'indexed': {'date-parts': [[2022, 5, 4]], 'date-time': '2022-05-04T14:40:45Z', 'timestamp': 1651675245514}, 'reference-count': 24, 'publisher': 'Public Library of Science (PLoS)', 'issue': '5', 'license': [ { 'start': { 'date-parts': [[2022, 5, 3]], 'date-time': '2022-05-03T00:00:00Z', 'timestamp': 1651536000000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'http://creativecommons.org/licenses/by/4.0/'}], 'content-domain': {'domain': ['www.plosone.org'], 'crossmark-restriction': False}, 'abstract': '<jats:sec id="sec001">\n' '<jats:title>Objectives</jats:title>\n' '<jats:p>Studies investigating the association between vitamin D and severity of COVID-19 have ' 'mixed results perhaps due to immunoassay assessment of total 25-hydroxyvitamin D (tD) (the ' 'sum of 25-hydroxyvitamin-D2 [25-OH-D2] and 25-hydroxyvitamin-D3 [25-OH-D3]). Liquid ' 'chromatography tandem mass spectrometry (LC-MS/MS) has high analytical specificity and ' 'sensitivity for 25-OH-D2 and 25-OH-D3, and thus enables a more accurate assessment of impact ' 'on COVID-19 outcomes.</jats:p>\n' '</jats:sec>\n' '<jats:sec id="sec002">\n' '<jats:title>Methods</jats:title>\n' '<jats:p>We established reference intervals for 25-OH-D3 and tD using LC-MS/MS. 25-OH-D2, ' '25-OH-D3 and tD were quantitated for 88 COVID-19 positive and 122 COVID-19 negative ' 'specimens. Chi-square or Fisher’s exact tests were used to test associations in binary ' 'variables. T-Tests or Wilcoxon rank sum tests were used for continuous variables. Cox ' 'proportional hazards were used to test associations between 25-OH-D3 or tD levels and length ' 'of stay (LOS). For mortality and ventilation, logistic regression models were used.</jats:p>\n' '</jats:sec>\n' '<jats:sec id="sec003">\n' '<jats:title>Results</jats:title>\n' '<jats:p>COVID-19 patients with deficient (&lt;20 ng/mL) levels of 25-OH-D3 had significantly ' 'longer LOS by 15.3 days. COVID-19 P patients with deficient (&lt;20 ng/mL) and insufficient ' '(&lt;30 ng/mL) of tD had significantly longer LOS by 12.1 and 8.2 days, respectively. ' 'Patients with insufficient levels of tD had significantly longer LOS by 13.7 days. COVID-19 ' 'patients with deficient serum 25-OH-D3 levels had significantly increased risk-adjusted odds ' 'of in-hospital mortality (OR [95% CI]: 5.29 [1.53–18.24]); those with insufficient 25-OH-D3 ' 'had significantly increased risk for requiring ventilation during hospitalization was found ' 'at LCMS insufficient cutoff (OR [95% CI]: 2.75 [1.10–6.90]).</jats:p>\n' '</jats:sec>\n' '<jats:sec id="sec004">\n' '<jats:title>Conclusions</jats:title>\n' '<jats:p>There is an inverse relationship of 25-hydroxyvitamin D levels and hospital LOS for ' 'COVID-19 patients. Vitamin D status is a predictor for severity of outcomes. LCMS results are ' 'useful for assessing the odds of mortality and the need for ventilation during ' 'hospitalization.</jats:p>\n' '</jats:sec>', 'DOI': '10.1371/journal.pone.0268038', 'type': 'journal-article', 'created': {'date-parts': [[2022, 5, 3]], 'date-time': '2022-05-03T17:28:39Z', 'timestamp': 1651598919000}, 'page': 'e0268038', 'update-policy': 'http://dx.doi.org/10.1371/journal.pone.corrections_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': '25-hydroxyvitamin D is a predictor of COVID-19 severity of hospitalized patients', 'prefix': '10.1371', 'volume': '17', 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-9362-1994', 'authenticated-orcid': True, 'given': 'Nguyen N.', 'family': 'Nguyen', 'sequence': 'first', 'affiliation': []}, {'given': 'Muppala N. P.', 'family': 'Raju', 'sequence': 'additional', 'affiliation': []}, {'given': 'Briget', 'family': 'da Graca', 'sequence': 'additional', 'affiliation': []}, {'given': 'Dapeng', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nada A.', 'family': 'Mohamed', 'sequence': 'additional', 'affiliation': []}, {'given': 'Manohar B.', 'family': 'Mutnal', 'sequence': 'additional', 'affiliation': []}, {'given': 'Arundhati', 'family': 'Rao', 'sequence': 'additional', 'affiliation': []}, {'given': 'Monica', 'family': 'Bennett', 'sequence': 'additional', 'affiliation': []}, {'given': 'Matthew', 'family': 'Gokingco', 'sequence': 'additional', 'affiliation': []}, {'given': 'Huy', 'family': 'Pham', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amin A.', 'family': 'Mohammad', 'sequence': 'additional', 'affiliation': []}], 'member': '340', 'published-online': {'date-parts': [[2022, 5, 3]]}, 'reference': [ { 'key': 'pone.0268038.ref001', 'doi-asserted-by': 'crossref', 'first-page': 'e58725', 'DOI': '10.1371/journal.pone.0058725', 'article-title': 'Influence of vitamin D status and vitamin D3 supplementation on genome ' 'wide expression of white blood cells: a randomized double-blind ' 'clinical trial', 'volume': '8', 'author': 'A Hossein-nezhad', 'year': '2013', 'journal-title': 'PLoS One'}, { 'key': 'pone.0268038.ref002', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/nu12010236', 'article-title': 'A Review of Micronutrients and the Immune System-Working in Harmony to ' 'Reduce the Risk of Infection', 'volume': '12', 'author': 'AF Gombart', 'year': '2020', 'journal-title': 'Nutrients'}, { 'key': 'pone.0268038.ref003', 'doi-asserted-by': 'crossref', 'first-page': '720', 'DOI': '10.1016/j.mayocp.2013.05.011', 'article-title': 'Vitamin D for health: a global perspective', 'volume': '88', 'author': 'A Hossein-nezhad', 'year': '2013', 'journal-title': 'Mayo Clin Proc'}, { 'key': 'pone.0268038.ref004', 'doi-asserted-by': 'crossref', 'first-page': '50', 'DOI': '10.4065/mcp.2010.0567', 'article-title': 'Vitamin D Insufficiency', 'volume': '86', 'author': 'TD Thacher', 'year': '2011', 'journal-title': 'Mayo Clin Proc'}, { 'key': 'pone.0268038.ref005', 'doi-asserted-by': 'crossref', 'first-page': '105751', 'DOI': '10.1016/j.jsbmb.2020.105751', 'article-title': 'Effect of calcifediol treatment and best available therapy versus best ' 'available therapy on intensive care unit admission and mortality among ' 'patients hospitalized for COVID-19: A pilot randomized clinical study', 'volume': '203', 'author': 'M Entrenas Castillo', 'year': '2020', 'journal-title': 'J Steroid Biochem Mol Biol'}, { 'issue': '9', 'key': 'pone.0268038.ref006', 'doi-asserted-by': 'crossref', 'first-page': '2757', 'DOI': '10.3390/nu12092757', 'article-title': 'Vitamin D deficiency and outcome of COVID-19 patients', 'volume': '12', 'author': 'A. Radujkovic', 'year': '2020', 'journal-title': 'Nutrients'}, { 'key': 'pone.0268038.ref007', 'article-title': 'Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza ' 'and COVID-19 Infections and Deaths', 'volume': '12', 'author': 'WB Grant', 'year': '2020', 'journal-title': 'Nutrients'}, { 'key': 'pone.0268038.ref008', 'article-title': 'Vitamin D status in hospitalized patients with SARS-CoV-2 infection', 'author': 'J. L. Hernández', 'year': '2020', 'journal-title': 'The Journal of clinical endocrinology and metabolism'}, { 'issue': '11', 'key': 'pone.0268038.ref009', 'doi-asserted-by': 'crossref', 'first-page': '1053', 'DOI': '10.1001/jama.2020.26848', 'article-title': 'Effect of a single high dose of vitamin D3 on hospital length of stay ' 'in patients with moderate to severe COVID-19: a randomized clinical ' 'trial', 'volume': '325', 'author': 'I. H. Murai', 'year': '2021', 'journal-title': 'Jama'}, { 'key': 'pone.0268038.ref010', 'doi-asserted-by': 'crossref', 'first-page': '1010', 'DOI': '10.1515/cclm-2019-0834', 'article-title': 'Evaluation of the 25- hydroxy vitamin D assay on a fully automated ' 'liquid chromatography mass spectrometry system, the Thermo Scientific ' 'Cascadion SM Clinical Analyzer with the Cascadion 25-hydroxy vitamin D ' 'assay in a routine clinical laboratory', 'volume': '58', 'author': 'SC Benton', 'year': '2020', 'journal-title': 'Clin Chem Lab Med'}, { 'key': 'pone.0268038.ref011', 'unstructured': 'CascadionTM SM 25-Hydroxy Vitamin D Assay [Internet]. [cited 2021 Jan ' '21]. Available from: ' 'https://www.thermofisher.com/order/catalog/product/10026927'}, { 'key': 'pone.0268038.ref012', 'unstructured': 'Practical Nonparametric Statistics, 3rd Edition | Wiley [Internet]. ' 'Wiley.com. [cited 2021 Jan 21]. Available from: ' 'https://www.wiley.com/en-us/Practical+Nonparametric+Statistics%2C+3rd+Edition-p-9780471160687'}, { 'issue': '1', 'key': 'pone.0268038.ref013', 'doi-asserted-by': 'crossref', 'first-page': '89', 'DOI': '10.1007/s11154-019-09532-w', 'article-title': 'Consensus statement from 2nd International Conference on Controversies ' 'in Vitamin D', 'volume': '21', 'author': 'A Giustina', 'year': '2020', 'journal-title': 'Rev Endocr Metab Disord'}, { 'issue': '2', 'key': 'pone.0268038.ref014', 'doi-asserted-by': 'crossref', 'first-page': '142', 'DOI': '10.1080/07315724.2003.10719287', 'article-title': 'Calcium absorption varies within the reference range for serum ' '25‐hydroxyvitamin D', 'volume': '22', 'author': 'RP Heaney', 'year': '2003', 'journal-title': 'J Am Coll Nutr'}, { 'issue': '11', 'key': 'pone.0268038.ref015', 'doi-asserted-by': 'crossref', 'first-page': '686', 'DOI': '10.5694/mja11.10301', 'article-title': 'Vitamin D and health in adults in Australia and New Zealand: a position ' 'statement', 'volume': '196', 'author': 'CA Nowson', 'year': '2012', 'journal-title': 'Med J Australia'}, { 'key': 'pone.0268038.ref016', 'unstructured': 'Ilex Medical, specializes in medical diagnostics Manufacture and sale of ' 'medical equipment—[Internet]. [cited 2021 Jan 22]. Available from: ' 'https://www.ilexmedical.com/'}, { 'key': 'pone.0268038.ref017', 'doi-asserted-by': 'crossref', 'first-page': 'e1008874', 'DOI': '10.1371/journal.ppat.1008874', 'article-title': 'Exploring links between vitamin D deficiency and COVID-19', 'volume': '16', 'author': 'M Mohan', 'year': '2020', 'journal-title': 'PLoS Pathog'}, { 'issue': '11', 'key': 'pone.0268038.ref018', 'doi-asserted-by': 'crossref', 'first-page': '3377', 'DOI': '10.3390/nu12113377', 'article-title': 'Vitamin D supplementation associated to better survival in hospitalized ' 'frail elderly COVID-19 patients: the GERIA-COVID quasi-experimental ' 'study', 'volume': '12', 'author': 'G. Annweiler', 'year': '2020', 'journal-title': 'Nutrients'}, { 'issue': '9', 'key': 'pone.0268038.ref019', 'doi-asserted-by': 'crossref', 'first-page': 'e0239252', 'DOI': '10.1371/journal.pone.0239252', 'article-title': 'SARS-CoV-2 positivity rates associated with circulating ' '25-hydroxyvitamin D levels', 'volume': '15', 'author': 'H. W. Kaufman', 'year': '2020', 'journal-title': 'PLoS One'}, { 'issue': '10', 'key': 'pone.0268038.ref020', 'doi-asserted-by': 'crossref', 'first-page': '2141', 'DOI': '10.1007/s40520-020-01677-y', 'article-title': 'Evidence for possible association of vitamin D status with cytokine ' 'storm and unregulated inflammation in COVID-19 patients', 'volume': '32', 'author': 'A Daneshkhah', 'year': '2020', 'journal-title': 'Aging Clin Exp Res'}, { 'issue': '1', 'key': 'pone.0268038.ref021', 'doi-asserted-by': 'crossref', 'first-page': '270', 'DOI': '10.4049/jimmunol.174.1.270', 'article-title': 'Suppressive effect of 1alpha,25-dihydroxyvitamin D3 on type I ' 'IFN-mediated monocyte differentiation into dendritic cells: impairment ' 'of functional activities and chemotaxis', 'volume': '174', 'author': 'MC Gauzzi', 'year': '2005', 'journal-title': 'J Immunol'}, { 'key': 'pone.0268038.ref022', 'doi-asserted-by': 'crossref', 'first-page': '194', 'DOI': '10.3389/fphys.2019.00194', 'article-title': 'Primary Vitamin D Target Genes of Human Monocytes', 'volume': '10', 'author': 'V Nurminen', 'year': '2019', 'journal-title': 'Front Physiol'}, { 'key': 'pone.0268038.ref023', 'doi-asserted-by': 'crossref', 'first-page': 'e2019722', 'DOI': '10.1001/jamanetworkopen.2020.19722', 'article-title': 'Association of Vitamin D Status and Other Clinical Characteristics With ' 'COVID-19 Test Results', 'volume': '3', 'author': 'DO Meltzer', 'year': '2020', 'journal-title': 'JAMA Netw Open'}, { 'issue': '6', 'key': 'pone.0268038.ref024', 'first-page': '1704S', 'article-title': 'Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential ' 'inhibition of Th1 functions', 'volume': '125', 'author': 'JM Lemire', 'year': '1995', 'journal-title': 'J Nutr'}], 'container-title': 'PLOS ONE', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://dx.plos.org/10.1371/journal.pone.0268038', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2022, 5, 3]], 'date-time': '2022-05-03T17:28:57Z', 'timestamp': 1651598937000}, 'score': 1, 'resource': {'primary': {'URL': 'https://dx.plos.org/10.1371/journal.pone.0268038'}}, 'subtitle': [], 'editor': [{'given': 'Pal Bela', 'family': 'Szecsi', 'sequence': 'first', 'affiliation': []}], 'short-title': [], 'issued': {'date-parts': [[2022, 5, 3]]}, 'references-count': 24, 'journal-issue': {'issue': '5', 'published-online': {'date-parts': [[2022, 5, 3]]}}, 'URL': 'http://dx.doi.org/10.1371/journal.pone.0268038', 'relation': {}, 'ISSN': ['1932-6203'], 'subject': ['Multidisciplinary'], 'container-title-short': 'PLoS ONE', 'published': {'date-parts': [[2022, 5, 3]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit